Infectious Disease
Gates MRI starts Phase III trial for tuberculosis vaccine
The Bill & Melinda Gates Medical Research Institute (Gates MRI) has dosed the first patient cohort in a Phase III…
TB potentially transmissible in undiagnosed cases
Tuberculosis (TB) is one of the oldest infectious diseases known to man and one of the “big three” [along with…
Merck to start trials investigating single dosing regimen of HPV vaccine
Merck & Co (MSD) plans to start two prospective clinical trials evaluating the safety and efficacy of a single-dose regimen…
Cases of tuberculosis could exceed pre-pandemic numbers in England
Tuberculosis (TB) is a bacterial infection that predominantly affects the lungs, and despite being preventable and treatable, TB remains one…
Replicate’s rabies vaccine demonstrates effectiveness in Phase I trial
US-based biotech Replicate Bioscience has announced positive preliminary data where its self-replicating RNA (srRNA) rabies vaccine, RBI-4000 achieved a strong…
Addimmune to investigate HIV gene therapy without SOC in Phase Ib trial
Addimmune will be launching a Phase Ib trial investigating its human immunodeficiency virus (HIV) candidate AGT103-T to review its safety…
Curevo looks to challenge GSK’s Shingrix with positive Phase II data
Curevo Vaccine’s varicella-zoster virus vaccine amezosvatein has achieved all primary endpoints, including demonstrating non-inferiority to GSK’s Shingrix in a Phase…
Inventprise completes dosing in Phase II pneumococcal vaccine study
Inventprise has completed vaccine administration in a Phase II study investigating the dosing range of its 25-valent pneumococcal conjugate vaccine…
Recibo’s shingles vaccine shows positive safety profile in Phase I trial
China-based Jiangsu Recbio Technology has announced positive results from a first-in-human (FIH) trial of a shingles vaccine. The trial compared…
Shionogi commences Phase III monovalent Covid-19 vaccine trial
Shionogi has commenced a Phase III clinical trial analysing additional doses of its monovalent Covid-19 vaccine against the XBB1.5 strain…